497 related articles for article (PubMed ID: 32808230)
1. Immunometabolism and Its Potential to Improve the Current Limitations of Immunotherapy.
Sheppard AD; Lysaght J
Methods Mol Biol; 2020; 2184():233-263. PubMed ID: 32808230
[TBL] [Abstract][Full Text] [Related]
2. New Immunometabolic Strategy Based on Cell Type-Specific Metabolic Reprogramming in the Tumor Immune Microenvironment.
Sung JY; Cheong JH
Cells; 2022 Feb; 11(5):. PubMed ID: 35269390
[TBL] [Abstract][Full Text] [Related]
3. Targeting immunometabolism of neoplasms by interleukins: A promising immunotherapeutic strategy for cancer treatment.
Zhu Z; Parikh P; Zhao H; Givens NT; Beck DB; Willson CM; Bai Q; Wakefield MR; Fang Y
Cancer Lett; 2021 Oct; 518():94-101. PubMed ID: 34153401
[TBL] [Abstract][Full Text] [Related]
4. Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy.
Bader JE; Voss K; Rathmell JC
Mol Cell; 2020 Jun; 78(6):1019-1033. PubMed ID: 32559423
[TBL] [Abstract][Full Text] [Related]
5. Immunometabolism: A 'Hot' Switch for 'Cold' Pediatric Solid Tumors.
Trends Cancer; ; . PubMed ID: 34183305
[TBL] [Abstract][Full Text] [Related]
6.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
7.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
8.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]